SlimAlert : May News

» Dec 06	» Nov 06	» Oct 06	» Sep 06	» Archive
» July 07	» June 07	» May 07	» April 07	» March 07

News »May 2006

Anonymity of Americans to get Rimonabant from Europe
Recent story of Sanofi-Aventis is that they plan to initiate Acomplia in Britain and Germany in mid-summer.Although, U.S. Food and Drugs Administration is unpredictable for taking any action on the approval of Acomplia in the United States at least until sometime in 2007.
Read More...

Confirmation of FDA action Delay on Diet Pill Acomplia
The Endocrinologic and Metabolic Drugs Advisory Committee, which had been scheduling to meet in November, now has discarded any kind of meeting which is related to the diet pill Acomplia.
Read More...

Sanofi-Aventis' Acomplia (Rimonabant) concerns perhaps continue
According to an analyst for Morgan Stanley, concerns over the safety look of weight-loss drug Acomplia (Rimonabant) set to continue until the drug is firmly established on the market.

FDA approves new smoking cessation drug after delaying Acomplia
The U.S. Food and drug Administration on May 11th approved the second nicotine-free prescription drug for smoking cessation after rejecting Sanofi's application to market acomplia. Read More...
Entry hope of Acomplia in Britain and Germany

CHMP has positive opinion on marketing Acomplia and Zimulti

The U.S. Food and drug Administration on May 11th approved the second nicotine-free prescription drug for smoking cessation after rejecting Sanofi's application to market acomplia. Read More...

Resource

Sanofi-Aventis' Acomplia (Rimonabant) concerns perhaps continue
According to an analyst for Morgan Stanley, concerns over the safety look of weight-loss drug Acomplia (Rimonabant) set to continue until the drug is firmly established on the market.

Disclaimer | Patient Declaration | About SlimAlert | Contact Us | Faqs | Terms & Conditions